Alnylam Pharmaceuticals
ALNY
#624
Rank
A$50.35 B
Marketcap
$390.39
Share price
1.06%
Change (1 day)
40.43%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company